Device Trial Radar · NCT05241756
FLACS in Pediatric Patients Using FEMTO LDV-Z8
Last checked: Nov 20, 2026Latest source record: Feb 16, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
12
Planned (sponsor's estimate)
Start
Jan 25, 2022
Primary completion
Jan 2023
Study completion Jan 2023
Sponsor
- Lead sponsor
- Ziemer Ophthalmic Systems AGNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 16, 2022
Design
- Study type
- Observational
- Who can join
- All sexes, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a single center prospective observational case series. The framework of this clinical investigation is post market clinical follow up of pediatric FLACS using the Femto LDV Z8. The intention is to investigate and supervise aspects particular to the pediatric use, and there is hence no alternative patient population. Primary outcome Related adverse events at the time of surgery, ophthalmic adverse events at 1 week, 1 month, 6 months. Secondary outcome Achieved vs aimed capsulotomy diameter * Aimed diameter to be calculated using the Bochum formula * Achieved diameter will be assessed using a ring caliper (Morcher 4.8 external diameter), (US patent MJ Tassignon) During the recruitment period, the legal representatives of all patients (and when applicable the patients) at the study site who are eligible for pediatric cataract surgery and fulfilling the eligibility criteria will be informed about the study and offered participation. The aim is to include 12 participants during the recruitment period of 6 months. Inclusion criteria are on purpose chosen very broad, in order to collect data from all types of pediatric cataract surgeries.The majority of the participants will be very young children, who cannot be involved in the informed consent procedure. Participants will nevertheless receive the patient information in a way adapted to their age and mental maturity, from investigators or members of the investigating team who are experienced in working with children. The study procedure is cataract surgery performed with the FEMTO LDV Z8 femtosecond laser. In this clinical investigation the CE marked products (the Femto LDV™ femtosecond laser and the FEMTO LDV™ Surgical Laser Procedure Packs for Cataract Surgery) are used without deviations from the intended use and indication for use. Intraoperatively the achieved capsulotomy diameter will assessed using a ring caliper (Morcher 4.8 external diameter) and compared with the aimed diameter calculated using the Bochum formula. Patients will return for follow-up visits at 1 week, 1 month, 6 months after the surgery.
Conditions
- Cataract in Child
Interventions
FLACS using FEMTO LDV-Z8Device
Performance of femtosecond laser-assisted capsulotomy in the anterior capsule.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of intraoperative and postoperative adverse eventsTime frame: Up to 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Antwerp University and University Hospital Antwerp (UZA)
Edegem, Antwerp, Belgium · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.